Session » (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
- 9:00AM-11:00AM
-
Abstract Number: 1952
Anti-MDA5 Associated Dermatomyositis: Clinical Features and Outcomes in a Predominantly African-American Case Series
- 9:00AM-11:00AM
-
Abstract Number: 1961
Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome
- 9:00AM-11:00AM
-
Abstract Number: 1945
Case Series of 6 Patients Exhibiting Myositis as a Rheumatologic Adverse Events Related to Cancer Immunotherapy in Two Spanish Hospitals
- 9:00AM-11:00AM
-
Abstract Number: 1965
Discordance Between Patient and Physician Perception of Disease Activity Among Patients with Idiopathic Inflammatory Myopathies: Results from the COVAD Study
- 9:00AM-11:00AM
-
Abstract Number: 1963
Effect of JAK-STAT Inhibition by Baricitinib and Tofacitinib on Disease Phenotype in a Mouse Model of Myositis
- 9:00AM-11:00AM
-
Abstract Number: 1954
Evaluation of Cancer Screening Methods in Patients Diagnosed with Inflammatory Muscle Disease at Kansas University Medical Center
- 9:00AM-11:00AM
-
Abstract Number: 1972
Evaluation of Myositis Autoantibodies as Predictors of Response to IVIG: Post-hoc Analysis of a Large Randomized, Double-Blind, Placebo-Controlled Phase III Trial
- 9:00AM-11:00AM
-
Abstract Number: 1960
From Clinical Amyopathy to Severe Oropharyngeal Dysphagia in Pure Dermatomyositis: A Greater Extent of Muscle Weakness Is Associated with a Higher Cancer Prevalence
- 9:00AM-11:00AM
-
Abstract Number: 1970
Impaired Health-Related Quality of Life in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Analysis from the COVAD Dataset
- 9:00AM-11:00AM
-
Abstract Number: 1967
Infectious Myopathies in an Urban Inflammatory Idiopathic Myopathy Cohort: Frequency and Impact on Disease Course and Treatment
- 9:00AM-11:00AM
-
Abstract Number: 1966
Investigating Esophageal Involvement in Anti-Synthetase Syndrome: How to Discover the Submerged?
- 9:00AM-11:00AM
-
Abstract Number: 1953
Mortality Trends in Polymyositis and Dermatomyositis in Mexico: A General Population-based Study from 2000 to 2019
- 9:00AM-11:00AM
-
Abstract Number: 1969
Multimorbidity and PROMIS Health Outcomes in Patients with Idiopathic Inflammatory Myopathies: Analysis from the COVAD Study
- 9:00AM-11:00AM
-
Abstract Number: 1971
Muscle Pathology in Patients with Primary Biliary Cholangitis
- 9:00AM-11:00AM
-
Abstract Number: 1947
National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England
- 9:00AM-11:00AM
-
Abstract Number: 1957
Non-Linear Mendelian Randomization Analyses Support a Role for Low Vitamin D Status in Sarcopenia Risk
- 9:00AM-11:00AM
-
Abstract Number: 1964
Penn State Registry of Inflammatory Myopathies (PRIMO) Provides Insights into Disease Features and Co-Morbidity Screening Utilization
- 9:00AM-11:00AM
-
Abstract Number: 1968
Pregnancy Outcomes in Idiopathic Inflammatory Myopathies: A Comparison to the General American Population
- 9:00AM-11:00AM
-
Abstract Number: 1959
Quantitative Scoring of High Resolution Chest Computed Tomography (HRCT) Images in Myositis and Antisynthetase Syndrome Related Interstitial Lung Disease in Comparison to Scleroderma Related Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1949
Relapse of Rapidly Progressive Interstitial Lung Disease in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibody-Positive Dermatomyositis
- 9:00AM-11:00AM
-
Abstract Number: 1955
Responsiveness and Minimal Important Difference of PROMIS Pain Interference, Fatigue, and Physical Function Forms in Adults with Idiopathic Inflammatory Myopathies
- 9:00AM-11:00AM
-
Abstract Number: 1956
Rituximab Treatment in Adult Patients with Idiopathic Inflammatory Myositis (IIM): A Systematic Review and Meta-analysis
- 9:00AM-11:00AM
-
Abstract Number: 1948
The Influence of Specific Myositis Antibodies on the Development of Interstitial Lung Disease
- 9:00AM-11:00AM
-
Abstract Number: 1950
Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study
- 9:00AM-11:00AM
-
Abstract Number: 1962
Toll-Like Receptor 7/8 Activation of Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and the Pathogenesis of Myositis
- 9:00AM-11:00AM
-
Abstract Number: 1951
Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis
- 9:00AM-11:00AM
-
Abstract Number: 1958
Validity, Responsiveness and Minimal Clinically Important Difference of EQ-5D-5L in Inflammatory Myositis: A Longitudinal Study